Exchange: NYSE·Updated 11:07 AM EDT
News
all
press releases
AbbVie Reports Positive Phase 3 Results For Etentamig In Multiple Myeloma
(RTTNews) - AbbVie (ABBV) on Thursday announced positive topline results from the Phase 3 CERVINO trial evaluating investigational etentamig in patients with relapsed/refractory multiple myeloma...
Nasdaq News: Markets
More News
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing...
PR Newswire
AbbVie Completes Acquisition of Apogee Therapeutics
AbbVie Completes Acquisition of Apogee Therapeutics AbbVie Completes Acquisition of Apogee Therapeutics PR Newswire NORTH CHICAGO, Ill., Sept. 3, 2026 Acquisition deepens AbbVie's robust immunology pipeline with diverse assets targeting dermatologic, respiratory and other inflammatory and...
PR Newswire
AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference PR Newswire NORTH CHICAGO, Ill., Sept. 3, 2026 NORTH CHICAGO, Ill., Sept. 3, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in...
PR Newswire
Can LLY's Merida Deal Boost Its M&A Push to Diversify Beyond GLP-1s?
Eli Lilly's 10th deal of 2026 expands its immunology pipeline, underscoring an aggressive push to build growth drivers beyond its blockbuster cardiometabolic franchise.
Zacks
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture PR Newswire NEW YORK, Sept. 1, 2026 NEW...
PR Newswire
GSK Stock Down 14% in Six Months: Time to Buy, Hold or Exit?
GSK's shares are down 14% in six months, but strong Specialty Medicines growth and a robust pipeline may support long-term gains.
Zacks
SkinMedica Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings
SkinMedica Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings SkinMedica Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings PR Newswire IRVINE, Calif., Sept. 1, 2026 In clinical testing, Barrier Calming Cream improved skin barrier support...
PR Newswire
Aging Population Drives Healthcare Growth: Stocks to Watch
AbbVie, Tandem Diabetes Care and Amgen are targeting aging-related healthcare growth through advances in immunology, diabetes and cardiovascular care.
Zacks
AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference
AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference PR Newswire NORTH CHICAGO, Ill., Aug. 31, 2026 NORTH CHICAGO, Ill., Aug. 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wells Fargo...
PR Newswire

Advertisement|Remove ads.